REVIEW
Year : 2019  |  Volume : 21  |  Issue : 5  |  Page : 433-437

Role of tumor-associated immune cells in prostate cancer: angel or devil?


Department of Urology, The Second Xiangya Hospital, Central South University, Changsha 410011, China

Correspondence Address:
Yin-Huai Wang
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha 410011
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aja.aja_47_19

Rights and Permissions

Prostate cancer is the most common malignancy in the reproductive system of older males. Androgen deprivation therapy (ADT) is an important treatment for prostate cancer patients. However, almost all prostate cancer patients unavoidably progress to the castration-resistant stage after ADT treatment. Recent studies have shown that tumor-associated immune cells play major roles in the initiation, progression, and metastasis of prostate cancer. Various phenotypes of tumor-associated immune cells have tumor-promoting or antitumor functions mediated by interacting with tumor cells. Here, we review the current knowledge of tumor-associated immune cells in prostate cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1517    
    Printed115    
    Emailed0    
    PDF Downloaded169    
    Comments [Add]    

Recommend this journal